ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomioma - ormoni ipofisari e ipotalamici e analoghi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
primolut nor
bayer ag - noretisterone - noretisterone
estracomb tts
novartis farma s.p.a. - noretisterone ed estrogeno - noretisterone ed estrogeno
estroclim plus
sigma-tau industrie farmaceutiche riunite spa - noretisterone ed estrogeno - noretisterone ed estrogeno
kliogest
novo nordisk a/s - noretisterone ed estrogeno - noretisterone ed estrogeno
estopause
dorom s.r.l. - noretisterone ed estrogeno - noretisterone ed estrogeno
merigest
novartis farma s.p.a. - noretisterone ed estrogeno - noretisterone ed estrogeno
activelle
novo nordisk s.p.a. - noretisterone ed estrogeno - noretisterone ed estrogeno
clinorette
resource medical uk ltd - noretisterone ed estrogeno - noretisterone ed estrogeno
estalis
novartis farma s.p.a. - noretisterone ed estrogeno - noretisterone ed estrogeno